Results 11 to 20 of about 3,921 (192)

Serum exosomal microRNA pathway activation in placenta accreta spectrum: pathophysiology and detectionAJOG Global Reports at a Glance

AJOG Global Reports
BACKGROUND: Placenta accreta spectrum disorders are a complex range of placental pathologies that are associated with significant maternal morbidity and mortality.
Jessian L. Munoz, MD, PhD, MPH, Brett D. Einerson, MD, Robert M. Silver, MD, Sureshkumar Mulampurath, PhD, Lauren S. Sherman, PhD, Pranela Rameshwar, PhD, Egle Bytautiene Prewit, PhD, Patrick S. Ramsey, MD, MSPH   +7 more
doaj   +4 more sources

Association between hypertensive disorders of pregnancy and placenta accreta spectrum

Pregnancy
Introduction Placenta accreta spectrum and hypertensive disorders of pregnancy are two significant contributors to severe maternal morbidity and fetal prematurity that may have related but opposite uteroplacental vascular origins.
Matthew Givens, Michelle P. Debbink, Lauren H. Theilen, Amanda A. Allshouse, Nathan Blue, Robert M. Silver, Brett D. Einerson   +6 more
doaj   +2 more sources

PLACENTA ACCRETA – RISK FACTORS, SURGICAL AND CLINICAL OUTCOME [PDF]

Journal of IMAB
Placenta accreta is a spectrum of antenatal diagnostic markers, surgical complications and life-threatening diagnoses. Objective: To evaluate the risk factors, the surgical complications and the clinical peripartal outcomes in the placenta accreta ...
Mariana Tsankova, Sergei Slavov, Ivan Kostov   +2 more
doaj   +2 more sources

Placenta accreta spectrum: A case series

Journal of Indira Gandhi Institute of Medical Sciences
The term “placenta accreta spectrum” describes the range of the pathologic adhesion of the placenta to the uterine wall. FIGO has classified it into three grades: placenta percreta, placenta increta, and placenta accreta.
Sadia Parween, Poonam Poonam, Dipali Prasad, Tarnija Vajpai, Ankita Jha   +4 more
doaj   +2 more sources

Routine screening for placenta accreta spectrum [PDF]

Best Practice & Research Clinical Obstetrics & Gynaecology, 2023
Screening for clinically significant placenta accreta spectrum (PAS) is possible with a high degree of accuracy (both sensitivity and specificity >90-95%). The group of women to focus on are those with placenta previa and one or more prior Cesarean deliveries. Screening for PAS not associated with placenta previa is not as productive, and several false
Amarnath Bhide, Bhide, A
openaire   +3 more sources

Clinical Characteristics, Prenatal Diagnosis and Outcomes of Placenta Accreta Spectrum in Different Placental Locations: A Retrospective Cohort Study

International Journal of Women's Health
Xiaoling Feng,1 Xun Mao,1 Jianlin Zhao2,3 1Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, People’s Republic of China; 2The Department of Obstetrics, The First Affiliated Hospital
Feng X, Mao X, Zhao J
doaj   +1 more source

A simple guide to ultrasound screening for placenta accreta spectrum for improving detection and optimizing management in resource limited settings [PDF]

, 2023
Placenta accreta spectrum is a pregnancy complication associated with severe morbidity and maternal mortality especially when not suspected antenatally and appropriate management instigated.
International Society of Placenta Accreta SPECTRUM (IS-PAS) Low- and Middle-Income Countries Working Group
core   +5 more sources

The relation between maternal obesity and placenta accreta spectrum: A multinational database study [PDF]

, 2021
INTRODUCTION: It has been suggested that women with obesity have increased risk of developing placenta accreta spectrum (PAS). It is unclear if this is independent of the increased risk of cesarean delivery seen with obesity itself. The aim of this study
International Society for Placenta accreta spectrum (IS-PAS)
core   +3 more sources

Training facilitated by interinstitutional collaboration and telemedicine: an alternative for improving results in the placenta accreta spectrum

AJOG Global Reports, 2021
Placenta accreta spectrum is a severe condition that requires trained, interdisciplinary group intervention. However, achieving the level of training that is required is difficult without academic programs or hospitals dedicated to teaching the necessary
Albaro José Nieto-Calvache, MD, José Miguel Palacios-Jaraquemada, MD, PhD, Lina María Vergara-Galliadi, MD, Alejandro Solo Nieto-Calvache, MD, Maria Andrea Zambrano, MD, Juan Manuel Burgos-Luna, MD   +5 more
doaj   +1 more source

Placenta accreta spectrum: treatment consensus in a resource-limited settingAJOG Global Reports at a Glance

AJOG Global Reports, 2023
BACKGROUND: Management options for placenta accreta spectrum disorder are multiple, without a clear picture of which one is superior. Management guidelines describe the use of a wide range of human and technological resources that are not always ...
Albaro José Nieto-Calvache, MD, José Enrique Sanín-Blair, MD, Marcela Buitrago, MD, Juliana Maya, MD, Jesús Andrés Benavides, MD   +4 more
doaj   +1 more source